Positive Healthcare posts a consolidated loss before interest, tax, depreciation and amortisation of £50,701 from its incorporation on 2 November to the end of June.
The loss after exceptional items and taxation was £252,766 on consolidated revenue of £1,140,993. The exceptional items comprise costs associated with the bond issue of £154,300.
A statement by chairman Gary Ashworth and chief executive Christopher Paul Ledbury said: "The first half of 2016 has been an exciting time of change and growth for Positive Healthcare. The acquisition of the majority stake of CCS and Fine Locums in June has given the Group an enlarged platform for growth.
"The increasing number of people living in the UK, combined with an ageing population, contribute to an insatiable appetite for free healthcare and as a result the NHS struggles to keep pace which leads to a growing demand for a flexible workforce plus a growing over-run into the private sector creating opportunities there too.
"The acquisitions coupled with our existing business gives a 3 times Bond cover on a normalised basis excluding fundraising fees.
"The company has invested in more fee earners, an updated CRM system and stronger marketing to attract nurses and doctors and service the new framework awards that have been won during the reporting period.
"We look forward to further organic growth and continue to evaluate strategic acquisitions in the sector."